Hepatitis C virus genotype 4 therapy: progress and challenges.

Abstract excerpt

The hepatitis C virus genotype 4 (HCV-4) is prevalent in Egypt, the Middle East and Africa. Recently, the epidemiology of HCV-4 has changed and this genotype has begun to cross borders and spread to several regions in Europe through immigration and injection drug use. HCV-4 has been considered a difficult-to-treat genotype based on the low sustained virological response (SVR) rates obtained with conventional...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Administration Schedule
• Share to Hepatitis C
• Share to Interferon-alpha